Parkside Investments’s Gilead Sciences GILD Stock Holding History

Parkside Investments’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-100	Closed	-$7K	–	125
2018 Q3	$7K	Buy	+100	New	+$7.55K	﹤0.01%	137

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Parkside Investments's GILD Position: Q4 2018 in Review

Parkside Investments sold out of Gilead Sciences (GILD) in Q4 2018, closing a stake of 100 shares — an estimated $7K sold.

Parkside Investments first reported a position in GILD in Q3 2018 and held it in 1 quarter. The position peaked at $7K in Q3 2018. 1,496 funds tracked by Wall St. Rank hold GILD as of Q4 2018.

Parkside Investments reported no remaining Gilead Sciences position as of Q4 2018 after selling out during the quarter.
Parkside Investments sold 100 Gilead Sciences shares in Q4 2018, an estimated $7K.
Parkside Investments first reported a position in Gilead Sciences in Q3 2018 and held it in 1 quarter.
Parkside Investments's Gilead Sciences position peaked at $7K in Q3 2018.
1,496 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2018.

Based on Parkside Investments's 13F filing for Q4 2018, filed 4 Feb 2019.